1773P ICECaP-2: Validation of metastasis-free survival (MFS) as a surrogate for overall survival (OS) in localized prostate cancer (LPC) in a more contemporary era

Autor:	Xie, W., Ravi, P., Buyse, M.E., Halabi, S., Kantoff, P.W., Sartor, O., Soule, H.R., Clarke, N., Collette, L., Dignam, J., James, N.D., Fizazi, K., Gillessen, S., Mottet, N., Murphy, L.R., Parulekar, W.R., Sandler, H., Tombal, B., Williams, S., Sweeney, C.
Zdroj:	In Annals of Oncology October 2023 34 Supplement 2:S958-S959
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu